Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics

Journal of Controlled Release

Volumn 65, Issue 1-2, 2000, Pages 203-220

  Stayton, Patrick S ^a   Hoffman, Allan S ^a   Murthy, Niren ^a   Lackey, Chantal ^a   Cheung, Charles ^a   Tan, Philip ^a   Klumb, Lisa A ^a   Chilkoti, Ashutosh ^c   Wilbur, F Scott ^d   Press, Oliver W ^b  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Duke University   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Engineered antibodies; Gene therapy; Smart polymers; Streptavidin; Targeted delivery

Indexed keywords

DNA; M PROTEIN; POLYMER;

ARTICLE; BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; GENE THERAPY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STABILITY; THERMODYNAMICS;

ANTIBODIES; DRUG DELIVERY SYSTEMS; GENE THERAPY; INDICATORS AND REAGENTS; POLYMERS; PROTEIN CONFORMATION; PROTEIN ENGINEERING; STREPTAVIDIN;

EID: 17644436393     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00236-9     Document Type: Article

References (39)

1. del Rosario R.B., Wahl R.L. Biotinylated iodo-polylysine for pretargeted radiation delivery. J. Nucl. Med. Sci. 4:1993;1147-1151.
2. Paganelli G., Pervez S., Siccardi A.G., Rowlinson G., Deleide G., Chiolerio F., Malcovati M., Scassellati G.A., Epenetos A.A. Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer. 45:1990;1184-1189.
3. Meyer B.F., Stoner M.L., Raphael C.L., Davis R.E., Herrmann R.P. Streptavidin-biotin immunotoxins: a new approach to purging bone marrow. Exp. Hematol. 19:1991;710-713.
4. Pardridge W.M. Recent developments in peptide drug delivery to the brain. Pharmacol. Toxicol. 71:1992;3-10.
5. Sheldon K., Baumal R., Marks A. Targeting of [111In]biocytin to cultured ovarian adenocarcinoma cells using covalent monoclonal antibody-streptavidin conjugates. Int. J. Rad. Appl. Instrum. A. 43:1992;1399-1402.
6. Chilkoti A., Long C.L., Schwartz B.L., Smith R.D., Stayton P.S. Chimeric engineered streptavidin tetramers as novel tools for bioseparations and drug delivery. Biotechnology. 13:1995;1198-1204.
7. Klumb L.A., Chu V., Stayton P.S. Energetic roles of hydrogen bonds at the ureido oxygen binding pocket in the streptavidin-biotin complex. Biochemistry. 37:1998;7657-7663.
8. Chilkoti A., Tan P.H., Stayton P.S. Site-directed mutagenesis studies of the high affinity streptavidin-biotin complex: contributions of tryptophan residues 79, 108, and 120. Proc. Natl. Acad. Sci. USA. 92:1995;1754-1758.
9. Chilkoti A., Stayton P.S. Molecular origins of the slow streptavidin-biotin dissociation kinetics. J. Am. Chem. Soc. 117:1995;622-628.
10. T.C. McDevitt, K.E. Nelson, P.S. Stayton, Constrained cell recognition peptides engineered into streptavidin, Biotechnology Progress (1999), in press.
11. Chu V., Freitag S., Le Trong I., Stenkamp R., Stayton P.S. Thermodynamic and structural consequences of flexible loop deletion by circular permutation in the streptavidin-biotin system. Prot. Sci. 7:1998;848-859.
12. Lackey C.A., Murthy N., Press O.W., Tirrell D.A., Hoffman A.S., Stayton P.S. pH-Dependent hemolytic activity of smart polymer-protein bioconjugates. Bioconjugate Chemistry. 10:1999;401-405.
13. N. Murthy, J.R. Robichaud, D.T. Tirrell, P.S. Stayton, A.S. Hoffman, The design and synthesis of polymers for endosomal disruption, J. Cont. Rel. (1999), in press.
14. Pantoliano M.W., Bird R.E., Johnson S., Asel E.D., Dodd S.W., Wood J.F., Hardman K.D. Conformational stability, folding and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed Escherichia coli. Biochemistry. 30:1991;10117-10125.
15. Gulliver G.A., Rumbley C.A., Carrero J., Voss E.W. Relative conformational stabilities of single-chain pocket and groove-shaped antibody active sites including HCDR transplant intermediates. Biochemistry. 34:1995;5158-5163.
16. Tan P.H., Sandmaier B.M., Stayton P.S. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency. Biophys. J. 75:1998;1473-1482.
17. Rowe E.S., Tanford C. Equilibrium and kinetics of the denaturation of a homogeneous human immunoglobulin light chain. Biochemistry. 12:1973;4822-4827.
18. Santoro M.M., Bolen D.W. Unfolding free energy changes determined by the linear extrapolation method: 1. Unfolding of phenylmethanesulfonyl a-chymotrypsin using different denaturants. Biochemistry. 27:1988;8069-8074.
19. Getzoff E.D., Tainer J.A., Olson A.J. Recognition and interactions controlling the assemblies of β-barrel domains. Biophys. J. 49:1986;191-206.
20. Jaenicke R. Folding and association of proteins. Prog. Biophys. Mol. Biol. 49:1987;117-237.
21. Zettlmeissl G., Rudolph R., Jaenicke R. Reconstitution of lactic dehydrogenase: Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry. 18:1979;5567-5571.
22. Knappick A., Pluckthun A. Engineered turns of a recombinant antibody improve its in vivo folding. Prot. Eng. 8:1995;81-89.
23. Tan P.H., Chu V., Stray J.E., Vessella R.L., Hamlin D.K., Wilbur D.S., Stayton P.S. Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubility. Immuno. Technol. 4:1998;107-114.
24. Sano T., Cantor C.R. A streptavidin-protein A chimera that allows one-step production of a variety of specific antibody conjugates. Bio/Technology. 9:1991;1378-1381.
25. Sano T., Glazer A.N., Cantor C.R. A streptavidin-metallothionein chimera that allows specific labeling of biological materials with many different heavy metal ions. Proc. Natl. Acad. Sci. USA. 89:1992;1534-1538.
26. Dubel S., Breitling F., Kontermann R., Schmidt T., Skerra A., Little M. Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv). J. Immunol. Methods. 178:1995;201-209.
27. Reznik G.O., Vajda S., Santo T., Cantor C.R. A streptavidin mutant with altered ligand-binding specificity. Proc. Natl. Acad. Sci. USA. 95:1998;13525-13530.
28. Reznik G.O., Vajda S., Smith C.L., Cantor C.R., Santo T. Streptavidins with intersubunit crosslinks have enhanced stability. Nat. Biotechnol. 14:1996;1007-1011.
29. Wilbur D.S., Stayton P.S., To R., Klumb L.A., Hamlin D.K., Vessella R.L., Buhler K.R., Stray J.E. Streptavidin in antibody pretargeting: Comparison of a recombinant streptavidin with two streptavidin mutant proteins and two commercially available streptavidin proteins. Bioconj. Chem. 9:1998;100-107.
30. Wilbur D.S., Hamlin D.K., Buhler K.R., Pathare P.M., Vessella R.L., Stayton P.S., To R. Streptavidin in antibody pretargeting. 2. Evaluation of methods for decreasing localization of streptavidinto kidney while retaining its tumor binding capacity. Bioconj. Chem. 9:1998;322-330.
31. Wilbur D.S., Hamlin D.K., Vessella R.L., Stray J.E., Buhler K.R., Stayton P.S., Klumb L.H., Pathare P.M., Weerawarna S.A. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' co-localization with recombinant streptavidin and avidin. Bioconj. Chem. 7:1996;689-702.
32. Haensler J., Szoka F. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconj. Chem. 4:1993;372-379.
33. Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269:1994;12918-12924.
34. 2 terminus of vesicular stomatitis virus glycoprotein is a pH-dependent hemolysin. J. Biol. Chem. 259:1984;4691-4694.
35. Subbarao N.K., Parente R.A., Szoka F.C., Nadasdi L., Pongracz K. pH-Dependent bilayer destabilization by an amphipathic peptide. Biochemistry. 26:1987;2964-2972.
36. Thomas J., Tirrell D.A. Polyelectrolyte-sensitized phospholipid vesicles. Acc. Chem. Res. 25:1992;336-342.
37. Ferrito M., Tirrell D.A. Poly(2-ethylacrylic acid). Macromol. Synth. 11:1992;59-62.
38. Chung J.C., Gross D.J., Thomas J.L., Tirrell D.A., Opsahl-Ong L.R. pH Sensitive, cation selective channels formed by a simple synthetic polyelectrolyte in artificial bilayer membranes. Macromolecules. 29:1996;4636-4641.
39. Tosteson M.T., Holmes S.J., Razin M., Tosteson D.C. Melittin lysis of red blood cells. J. Membrane Biol. 87:1985;35-44.